General Assembly Committee Bill No. 396
January Session, 2011 LCO No. 2647
*02647SB00396INS*
Referred to Committee on Insurance and Real Estate
Introduced by:
(INS)
General Assembly
Committee Bill No. 396
January Session, 2011
LCO No. 2647
*02647SB00396INS*
Referred to Committee on Insurance and Real Estate
Introduced by:
(INS)
AN ACT CONCERNING INSURANCE COVERAGE FOR CERTAIN THERAPIES AND PRESCRIPTION DRUGS FOR THE TREATMENT OF PROSTATE CANCER.
Be it enacted by the Senate and House of Representatives in General Assembly convened:
Section 1. Section 38a-492g of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2012):
(a) Each individual health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 delivered, issued for delivery, renewed, amended or continued in this state [on or after January 1, 2000,] shall provide coverage for laboratory and diagnostic tests, including, but not limited to, prostate specific antigen (PSA) tests, to screen for prostate cancer for men who are symptomatic [,] or whose biological father or brother has been diagnosed with prostate cancer, and for all men fifty years of age or older.
(b) Each such policy shall provide coverage for external beam radiation therapy and brachytherapy for the treatment of prostate cancer, provided such therapies are (1) medically necessary, and (2) ordered by a licensed physician.
(c) Each such policy that provides coverage for prescription drugs shall provide coverage for phosphodiesterase-5 inhibitor prescription drugs for the treatment of erectile dysfunction resulting from a radical prostatectomy.
Sec. 2. Section 38a-518g of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2012):
(a) Each group health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 delivered, issued for delivery, renewed, amended or continued in this state [on or after January 1, 2000,] shall provide coverage for laboratory and diagnostic tests, including, but not limited to, prostate specific antigen (PSA) tests, to screen for prostate cancer for men who are symptomatic [,] or whose biological father or brother has been diagnosed with prostate cancer, and for all men fifty years of age or older.
(b) Each such policy shall provide coverage for external beam radiation therapy and brachytherapy for the treatment of prostate cancer, provided such therapies are (1) medically necessary, and (2) ordered by a licensed physician.
(c) Each such policy that provides coverage for prescription drugs shall provide coverage for phosphodiesterase-5 inhibitor prescription drugs for the treatment of erectile dysfunction resulting from a radical prostatectomy.
This act shall take effect as follows and shall amend the following sections:
Section 1 January 1, 2012 38a-492g
Sec. 2 January 1, 2012 38a-518g
This act shall take effect as follows and shall amend the following sections:
Section 1
January 1, 2012
38a-492g
Sec. 2
January 1, 2012
38a-518g
Statement of Purpose:
To require health insurance coverage for (1) external radiation beam therapy and brachytherapy for the treatment of prostate cancer, and (2) phosphodiesterase-5 inhibitor prescription drugs for the treatment of erectile dysfunction resulting from a radical prostatectomy.
[Proposed deletions are enclosed in brackets. Proposed additions are indicated by underline, except that when the entire text of a bill or resolution or a section of a bill or resolution is new, it is not underlined.]
Co-Sponsors: SEN. CRISCO, 17th Dist.
Co-Sponsors:
SEN. CRISCO, 17th Dist.
S.B. 396